Botanical species · safety record

Aster tataricus

The EFSA Compendium of Botanicals holds 7 constituent measurements and 1 adverse-effect record for Aster tataricus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Aster tataricus L.f.

7Constituent measurements

1Safety records

5Cited sources

114Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 114 licensed products naming Aster tataricus as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA

Source material stated

Dried root and rhizome
Herb
New material
Radix
Rhizome
Rhizome(s)
Root
Root and Rhizome

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Cyclic pentapeptides	Roots and other underground parts	Solvent extraction	—	HPLC-DAD	Resolve DOI
Saponins	Roots and other underground parts	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Triterpene saponins	Roots and other underground parts	Solvent extraction	—	HPLC with standard detection methods	Resolve DOI
Chrysophanol	Roots and other underground parts	—	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Emodin	Roots and other underground parts	—	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Physcion	Roots and other underground parts	—	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Scopoletin	Unspecified	—	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Hepatotoxicity	Liver	Roots and other underground parts	Solvent extraction	House mouse (as animal)	Short-term toxicity	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Wang Guo-yan., Wu Tao., Lin Ping-chuan., Chou Gui-xin., Wang Zheng-tao. Phenolic compounds isolated from rhizoma of Aster tataricus. Zhongguo zhongyao zazhi, 2003, vol. 28, no. 10, p. 946-948.
Zhao, Dong-Xia., Hu, Bing-Qiang., Zhang, Mian., Zhang, Chao-Feng., Xu, Xiang-Hong. Simultaneous separation and determination of phenolic acids, pentapeptides, and triterpenoid saponins in the root of Aster tataricus by high-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight mass spectrometry. JOURNAL OF SEPARATION SCIENCE, 2015, vol. 38, no. 4, p. 571-575. DOI
Lu, Yanhua., Wang, Zhengtao., Xu, Luoshan., Wu, Zibin. Polyphenolic compounds from Aster tataricus.. Zhongcaoyao, 2002, vol. 33, no. 1, p. 17-18.
Liu, Xiaodong., Cao, Peipei., Zhang, Chaofeng., Xu, Xianghong., Zhang, Mian. Screening and analyzing potential hepatotoxic compounds in the ethanol extract of Asteris Radix by HPLC/DAD/ESI-MSn technique. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, vol. 67-68, p. 51-62. DOI
Nagao, Tsuneatsu., Hachiyama, Shizuko., Okabe, Hikaru., Yamauchi, Tatsuo. Studies on the constituents of Aster tataricus L.f. II. Structures of aster saponins isolated from the root.. Chemical & Pharmaceutical Bulletin, 1989, vol. 37, no. 8, p. 1977-83. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature